Susquehanna International Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-557,300
| Closed | -$47.4M | – | 12105 |
|
|
2020
Q3 | $47.4M | Sell |
557,300
-7,000
| -1% | -$354K | 0.01% | 890 |
|
|
2020
Q2 | $20M | Buy |
564,300
+145,600
| +35% | +$4.26M | ﹤0.01% | 1428 |
|
|
2020
Q1 | $5.64M | Sell |
418,700
-92,300
| -18% | -$1.55M | ﹤0.01% | 2425 |
|
|
2019
Q4 | $10.8M | Sell |
511,000
-518,800
| -50% | -$9.15M | ﹤0.01% | 2005 |
|
|
2019
Q3 | $13.7M | Buy |
1,029,800
+665,900
| +183% | +$9.79M | ﹤0.01% | 1658 |
|
|
2019
Q2 | $5.05M | Buy |
363,900
+6,300
| +2% | +$94.8K | ﹤0.01% | 2698 |
|
|
2019
Q1 | $6.87M | Sell |
357,600
-496,500
| -58% | -$8M | ﹤0.01% | 2106 |
|
|
2018
Q4 | $12.2M | Sell |
854,100
-154,300
| -15% | -$3.06M | ﹤0.01% | 1429 |
|
|
2018
Q3 | $21M | Buy |
1,008,400
+134,200
| +15% | +$3.18M | 0.01% | 1291 |
|
|
2018
Q2 | $20.7M | Buy |
874,200
+99,900
| +13% | +$2.01M | 0.01% | 1270 |
|
|
2018
Q1 | $11.3M | Buy |
774,300
+228,700
| +42% | +$3.74M | ﹤0.01% | 1664 |
|
|
2017
Q4 | $8.82M | Buy |
545,600
+19,100
| +4% | +$225K | ﹤0.01% | 1928 |
|
|
2017
Q3 | $7.36M | Buy |
526,500
+11,400
| +2% | +$114K | ﹤0.01% | 2072 |
|
|
2017
Q2 | $4.55M | Buy |
515,100
+165,300
| +47% | +$1.16M | ﹤0.01% | 2532 |
|
|
2017
Q1 | $2.26M | Buy |
349,800
+221,900
| +173% | +$1.12M | ﹤0.01% | 3484 |
|
|
2016
Q4 | $469K | Sell |
127,900
-5,300
| -4% | -$15.7K | ﹤0.01% | 7135 |
|
|
2016
Q3 | $433K | Sell |
133,200
-154,800
| -54% | -$433K | ﹤0.01% | 6336 |
|
|
2016
Q2 | $668K | Buy |
288,000
+144,500
| +101% | +$483K | ﹤0.01% | 5619 |
|
|
2016
Q1 | $359K | Sell |
143,500
-293,500
| -67% | -$660K | ﹤0.01% | 6965 |
|
|
2015
Q4 | $1.34M | Buy |
437,000
+13,500
| +3% | +$37.7K | ﹤0.01% | 4822 |
|
|
2015
Q3 | $728K | Sell |
423,500
-317,100
| -43% | -$809K | ﹤0.01% | 6380 |
|
|
2015
Q2 | $3.01M | Buy |
740,600
+320,800
| +76% | +$1.31M | ﹤0.01% | 3843 |
|
|
2015
Q1 | $1.61M | Sell |
419,800
-80,800
| -16% | -$351K | ﹤0.01% | 4747 |
|
|
2014
Q4 | $2.4M | Sell |
500,600
-62,300
| -11% | -$246K | ﹤0.01% | 4104 |
|
|
2014
Q3 | $2.09M | Sell |
562,900
-132,000
| -19% | -$446K | ﹤0.01% | 4528 |
|
|
2014
Q2 | $2.54M | Sell |
694,900
-76,300
| -10% | -$280K | ﹤0.01% | 4201 |
|
|
2014
Q1 | $3.25M | Sell |
771,200
-238,100
| -24% | -$1.18M | ﹤0.01% | 3520 |
|
|
2013
Q4 | $4.64M | Buy |
1,009,300
+251,900
| +33% | +$1.12M | ﹤0.01% | 3049 |
|
|
2013
Q3 | $4.69M | Sell |
757,400
-48,400
| -6% | -$279K | ﹤0.01% | 2835 |
|
|
2013
Q2 | $4.38M | Buy |
+805,800
| New | +$2.65M | ﹤0.01% | 2789 |
|
Susquehanna International Group's IMMU Position: Q4 2020 in Review
Susquehanna International Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 140,618 shares — an estimated $12M sold.
Susquehanna International Group first reported a position in IMMU in Q2 2013 and held it in 27 quarters. The position peaked at $27.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Susquehanna International Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Susquehanna International Group sold 140,618 Immunomedics Inc shares in Q4 2020, an estimated $12M.
- Susquehanna International Group first reported a position in Immunomedics Inc in Q2 2013 and held it in 27 quarters.
- Susquehanna International Group's Immunomedics Inc position peaked at $27.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.